Selvita S.A. Logo

Selvita S.A.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Selvita S.A. is one of Europe's largest preclinical Contract Research Organizations (CROs), providing integrated services for the pharmaceutical, biopharmaceutical, and chemical industries. The company specializes in drug discovery and development, with a mission to bridge the gap between early discovery and the clinical stages. Selvita offers a comprehensive scope of solutions, including high-quality research and development support and advanced analytical services. It supports client projects across various therapeutic areas, helping to accelerate the development of new therapies for patients.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Selvita S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-22 17:17
Regulatory News Service
Otrzymanie istotnych zleceń przez spółkę zależną Selvita S.A. / Receipt of a si…
English 2.2 KB
2025-07-22 17:17
Regulatory News Service
Otrzymanie istotnych zleceń przez spółkę zależną Selvita S.A. / Receipt of a si…
Polish 1.7 KB
2025-06-30 20:46
Board/Management Information
Powołanie Członków Zarządu Selvita S.A. na kolejną kadencję / Appointment of th…
English 9.2 KB
2025-06-30 20:46
Board/Management Information
Powołanie Członków Zarządu Selvita S.A. na kolejną kadencję / Appointment of th…
Polish 9.5 KB
2025-06-30 16:02
Board/Management Information
Powołanie Członków Rady Nadzorczej Selvita S.A. na kolejną kadencję. / Appointm…
English 8.5 KB
2025-06-30 16:02
Post-Annual General Meeting Information
Powołanie Członków Rady Nadzorczej Selvita S.A. na kolejną kadencję. / Appointm…
Polish 8.8 KB
2025-06-30 16:00
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 2.0 KB
2025-06-30 15:58
Post-Annual General Meeting Information
Resolutions
English 291.0 KB
2025-06-30 15:58
Post-Annual General Meeting Information
Uchwały
Polish 202.2 KB
2025-06-30 15:58
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie Selvita S.A. / Resolu…
Polish 746 bytes
2025-06-26 21:21
Regulatory News Service
Otrzymanie istotnego zlecenia przez spółkę zależną Selvita S.A. - Content (PL)
Polish 2.4 KB
2025-06-24 21:17
Regulatory News Service
Otrzymanie istotnego zlecenia przez spółkę zależną Selvita S.A. - Content (PL)
Polish 1.6 KB
2025-06-24 18:05
Board/Management Information
Zgłoszenie kandydata
Polish 209.6 KB
2025-06-24 18:05
Board/Management Information
Zgłoszenie kandydata do Rady Nadzorczej Spółki / Submission of Candidate to the…
Polish 1.1 KB
2025-06-06 18:31
Board/Management Information
Wniosek
Polish 162.4 KB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL